Efficacy and safety of lemborexant in midlife women with insomnia disorder

OBJECTIVE: Insomnia is common in midlife women. The efficacy and safety of lemborexant (LEM), a competitive dual orexin receptor antagonist, was assessed for 12 months in a subgroup of midlife women (age, 40-58 y) from Study E2006-G000-303 (Study 303; SUNRISE-2). METHODS: This was a randomized, doub...

Descripción completa

Detalles Bibliográficos
Autores principales: Terauchi, Masakazu, Cheng, Jocelyn Y., Yardley, Jane, Pinner, Kate, Moline, Margaret, Malhotra, Manoj, Inabe, Kanako, Nishida, Maika, Pappadopulos, Elizabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Original Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10389212/
https://www.ncbi.nlm.nih.gov/pubmed/37339396
http://dx.doi.org/10.1097/GME.0000000000002209

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10389212/
https://www.ncbi.nlm.nih.gov/pubmed/37339396
http://dx.doi.org/10.1097/GME.0000000000002209

Ejemplares similares